• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Director Breen Edward D received a gift of 77,750 shares and gifted 231,654 shares, decreasing direct ownership by 34% to 292,792 units (SEC Form 4)

    8/23/24 7:38:32 AM ET
    $DD
    Major Chemicals
    Industrials
    Get the next $DD alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    BREEN EDWARD D

    (Last) (First) (Middle)
    CHESTNUT RUN PLAZA 730
    974 CENTRE ROAD

    (Street)
    WILMINGTON DE 19805

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    DuPont de Nemours, Inc. [ DD ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    08/21/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 08/21/2024 G V 77,750(1) A $0.00 524,445.9892(2) D
    Common Stock 08/21/2024 G 231,654(3) D $0.00 292,791.9892 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents annuity payments back to Mr. Breen from 2021 GRAT 19, 2021 GRAT 20, 2022 GRAT 15 and 2023 GRAT 12.
    2. Includes acquisition of shares pursuant to dividend reinvestment.
    3. Represents the funding of new GRAT 2024-9.
    Peter W. Hennessey by Power of Attorney 08/23/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DD

    DatePrice TargetRatingAnalyst
    7/3/2025$75.00 → $85.00Buy
    Citigroup
    4/15/2025$75.00Underperform → Neutral
    BofA Securities
    4/14/2025$81.00Sector Weight → Overweight
    KeyBanc Capital Markets
    2/13/2025$85.00 → $89.00Underweight → Equal Weight
    Barclays
    1/17/2025$91.00Peer Perform → Outperform
    Wolfe Research
    10/7/2024$88.00 → $84.00Equal Weight → Underweight
    Barclays
    5/28/2024$85.00 → $95.00Neutral → Buy
    Citigroup
    5/24/2024$80.00 → $103.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $DD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DuPont Schedules First Quarter 2026 Earnings Conference Call

    WILMINGTON, Del., April 16, 2026 /PRNewswire/ -- DuPont (NYSE:DD) will release its first quarter 2026 financial results at 6:00 a.m. ET on Tuesday, May 5, 2026. In addition, the company will host a conference call at 8:00 a.m. ET that day. The event will be webcast live and can be accessed on DuPont's Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website.      The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5994046.About DuPo

    4/16/26 7:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Announces Regularly Quarterly Dividend on Common Stock

    WILMINGTON, Del., April 15, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced that its Board of Directors has declared a quarterly dividend of twenty cents ($0.20) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on May 29, 2026, to holders of record of said stock at the close of business on May 15, 2026. About DuPontDuPont (NYSE:DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More info

    4/15/26 4:30:00 PM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Launches DuPont™ AmberChrom™ XT SL Chromatography Resins to Simplify Biopharmaceutical Workflows

    New slurried chromatography resins eliminate resin hydration step to help accelerate downstream purification of oligonucleotides and peptidesWILMINGTON, Del., April 14, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced the launch of DuPont™ AmberChrom™ XT20 SL and XT30 SL chromatography resins, expanding its bioprocessing portfolio to help manufacturers streamline purification operations for oligonucleotide and peptide therapeutics. Oligonucleotide and peptide therapeutics are a growing class of targeted medicines used to treat a range of diseases—particularly genetics and r

    4/14/26 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cutler Alexander M was granted 999 shares, increasing direct ownership by 1% to 76,609 units (SEC Form 4)

    4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    3/3/26 4:30:25 PM ET
    $DD
    Major Chemicals
    Industrials

    Director Lowery Frederick M. was granted 774 shares, increasing direct ownership by 2% to 35,290 units (SEC Form 4)

    4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    3/3/26 4:29:39 PM ET
    $DD
    Major Chemicals
    Industrials

    Director Macpherson Donald G was granted 216 shares, increasing direct ownership by 23% to 1,162 units (SEC Form 4)

    4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    3/3/26 4:29:11 PM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    SEC Filings

    View All

    $DD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    SEC Form DEFA14A filed by DuPont de Nemours Inc.

    DEFA14A - DuPont de Nemours, Inc. (0001666700) (Filer)

    4/15/26 4:33:19 PM ET
    $DD
    Major Chemicals
    Industrials

    DuPont de Nemours Inc. filed SEC Form 8-K: Leadership Update

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    4/15/26 4:14:11 PM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form DEFA14A filed by DuPont de Nemours Inc.

    DEFA14A - DuPont de Nemours, Inc. (0001666700) (Filer)

    4/10/26 4:02:11 PM ET
    $DD
    Major Chemicals
    Industrials

    Citigroup reiterated coverage on DuPont with a new price target

    Citigroup reiterated coverage of DuPont with a rating of Buy and set a new price target of $85.00 from $75.00 previously

    7/3/25 9:18:04 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont upgraded by BofA Securities with a new price target

    BofA Securities upgraded DuPont from Underperform to Neutral and set a new price target of $75.00

    4/15/25 8:43:17 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded DuPont from Sector Weight to Overweight and set a new price target of $81.00

    4/14/25 8:04:47 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DuPont de Nemours Inc.

    SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

    11/12/24 11:54:03 AM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by DuPont de Nemours Inc. (Amendment)

    SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

    2/13/24 4:55:53 PM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by DuPont de Nemours Inc.

    SC 13G - DuPont de Nemours, Inc. (0001666700) (Subject)

    2/9/24 11:49:03 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Financials

    Live finance-specific insights

    View All

    DuPont Schedules First Quarter 2026 Earnings Conference Call

    WILMINGTON, Del., April 16, 2026 /PRNewswire/ -- DuPont (NYSE:DD) will release its first quarter 2026 financial results at 6:00 a.m. ET on Tuesday, May 5, 2026. In addition, the company will host a conference call at 8:00 a.m. ET that day. The event will be webcast live and can be accessed on DuPont's Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website.      The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5994046.About DuPo

    4/16/26 7:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Announces Regularly Quarterly Dividend on Common Stock

    WILMINGTON, Del., April 15, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced that its Board of Directors has declared a quarterly dividend of twenty cents ($0.20) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on May 29, 2026, to holders of record of said stock at the close of business on May 15, 2026. About DuPontDuPont (NYSE:DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More info

    4/15/26 4:30:00 PM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Announces Regular Quarterly Dividend on Common Stock

    WILMINGTON, Del., Feb. 19, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced that its Board of Directors has declared a quarterly dividend of twenty cents ($0.20) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on March 16, 2026, to holders of record of said stock at the close of business on March 2, 2026. About DuPont DuPont (NYSE:DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More i

    2/19/26 5:22:00 PM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Leadership Updates

    Live Leadership Updates

    View All

    Arclin Completes Acquisition of the DuPont™ Aramids Business, Including Iconic Kevlar® and Nomex® Brands

    ALPHARETTA, Ga., April 1, 2026 /CNW/ -- Arclin, a global materials science company, today announced that it has completed the acquisition of DuPont's Aramids business, including the renowned Kevlar® and Nomex® brands, for approximately $1.8 billion. The transaction marks a transformational milestone for Arclin, significantly expanding its scale, capabilities, and presence across life-critical industries. Arclin is a portfolio company of an affiliate of TJC, L.P. Arclin Completes Acquisition of the DuPont™ Aramids Business, Including Iconic Kevlar® and Nomex® Brands"Kevlar® and N

    4/1/26 7:45:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Announces Appointment of D.G. Macpherson to Board of Directors

    WILMINGTON, Del., Jan. 20, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of D.G. Macpherson to its Board of Directors, effective immediately. "We are very pleased to welcome D.G. to the DuPont board," said Lori Koch, DuPont Chief Executive Officer. "D.G. brings deep expertise in operational excellence, supply chain optimization, and business transformation, which will be invaluable as we execute our growth strategy and deliver long-term value to shareholders, customers, and employees. His passion for innovation and commitment to continuous improvement m

    1/20/26 4:15:00 PM ET
    $DD
    Major Chemicals
    Industrials

    Solstice Advance Materials and Qnity Electronics Set to Join S&P 500; Others to Join S&P SmallCap 600

    NEW YORK, Oct. 27, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P SmallCap 600: Solstice Advance Materials Inc. (NASD: SOLS) will replace CarMax Inc. (NYSE:KMX) in the S&P 500, and CarMax will replace USANA Health Sciences Inc. (NYSE:USNA) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, October 31. S&P 500 and 100 constituent Honeywell International Inc. (NASD: HON) is spinning off Solstice Advance Materials in a transaction expected to be completed on October 30. Post spin-off, Honeywell International will remain in the S&P 500 and 100. CarMax and USANA Health Sciences no longer represent the large cap and small c

    10/27/25 6:10:00 PM ET
    $CAL
    $DD
    $EMN
    Shoe Manufacturing
    Consumer Discretionary
    Major Chemicals
    Industrials